{"acquisitions":[],"changes":[],"country":"ES","description":"Genetic medicine company using engineered inteins to overcome gene delivery size limitations for rare diseases","domain":"splicebio.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":41.38258,"lng":2.177073,"location":"Barcelona, Spain","multiples":[],"name":"Splice Bio","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":135000000,"connectionsAmong":[],"currency":"USD","date":"2025-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"splicebio-com-2025-06-01-series-b","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-04-30","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"splicebio-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-04-30","status":"attributed","url":null},{"fact":"existence","publisher":"splicebio.com","retrievedAt":"2026-04-30","status":"self-reported","url":"https://splicebio.com"},{"fact":"description","publisher":"splicebio.com","retrievedAt":"2026-04-30","status":"self-reported","url":"https://splicebio.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":215000000,"traction":[],"updatedAt":"2026-04-30","valuations":[]}